|
I10
|
Essential (primary) hypertension
|
38.7
|
36.2
|
1.07 (0.94, 1.22)
|
|
M54
|
Dorsalgia
|
35.3
|
30.3
|
1.16 (1.01, 1.34) b
|
|
E78
|
Disorders of lipoprotein metabolism and other lipidemias
|
33.7
|
25.1
|
1.34 (1.15, 1.56) b
|
|
Z12
|
Encounter for screening for malignant neoplasms
|
31.3
|
30.0
|
1.04 (0.89, 1.22)
|
|
H52
|
Disorders of refraction and accommodation
|
27.3
|
23.6
|
1.16 (0.97, 1.38)
|
|
Z30
|
Encounter for contraceptive management
|
22.5
|
21.2
|
1.06 (0.87, 1.30)
|
|
N89
|
Other noninflammatory disorders of vagina
|
21.8
|
18.0
|
1.21 (0.99, 1.48)
|
|
J06
|
Acute upper respiratory infections of multiple and unspecified sites
|
21.5
|
18.8
|
1.14 (0.93, 1.40)
|
|
Z01
|
Encounter for other specified exam without complaint, suspected or reported dx
|
20.7
|
14.0
|
1.47 (1.19, 1.82) b
|
|
F32
|
Major depressive disorder, single episode
|
16.2
|
13.3
|
1.22 (0.95, 1.55)
|
|
Z00
|
Encounter for general exam without complaint, suspected or reported dx
|
15.9
|
14.4
|
1.11 (0.87, 1.42)
|
|
E66
|
Overweight and obesity
|
15.9
|
11.2
|
1.43 (1.11, 1.83) b
|
|
I25
|
Chronic ischemic heart disease
|
15.7
|
9.0
|
1.74 (1.35, 2.25) b
|
|
F45
|
Somatoform disorders
|
15.4
|
12.1
|
1.27 (0.98, 1.63)
|
|
E11
|
Type 2 diabetes mellitus
|
14.9
|
11.6
|
1.28 (0.99, 1.66)
|
|
Z25
|
Need for immunization against other single viral diseases
|
14.3
|
13.1
|
1.09 (0.84, 1.42)
|
|
M53
|
Other and unspecified dorsopathies, not elsewhere classified
|
14.3
|
10.2
|
1.40 (1.08, 1.83) b
|
|
E04
|
Other nontoxic goiter
|
14.1
|
10.8
|
1.30 (1.00, 1.69)
|
|
M47
|
Spondylosis
|
13.8
|
12.2
|
1.13 (0.86, 1.47)
|
|
R10
|
Abdominal and pelvic pain
|
13.3
|
11.4
|
1.17 (0.89, 1.53)
|
|
M17
|
Osteoarthritis of knee
|
13.3
|
10.1
|
1.31 (1.00, 1.73)
|
|
N39
|
Other disorders of urinary system
|
13.0
|
9.4
|
1.38 (1.04, 1.82) b
|
|
K29
|
Gastritis and duodenitis
|
12.7
|
9.7
|
1.32 (0.99, 1.75)
|
|
N95
|
Menopausal and other perimenopausal disorders
|
12.5
|
8.6
|
1.46 (1.09, 1.94) b
|
|
J45
|
Asthma
|
11.9
|
7.0
|
1.70 (1.26, 2.29) b
|
|
D22
|
Melanocytic nevi
|
11.7
|
9.2
|
1.28 (0.95, 1.71)
|
|
E03
|
Other hypothyroidism
|
11.7
|
9.5
|
1.23 (0.92, 1.66)
|
|
J30
|
Vasomotor and allergic rhinitis
|
11.7
|
8.8
|
1.32 (0.98, 1.78)
|
|
R42
|
Dizziness and giddiness
|
11.1
|
6.0
|
1.84 (1.35, 2.52) b
|
|
F43
|
Reaction to severe stress, and adjustment disorders
|
10.9
|
7.0
|
1.56 (1.15, 2.14) b
|
|
E14
|
Unspecified diabetes mellitus
|
10.9
|
6.4
|
1.69 (1.23, 2.31) b
|
|
A09
|
Infectious gastroenteritis and colitis, unspecified
|
10.6
|
6.3
|
1.69 (1.23, 2.33) b
|
|
M79
|
Other and unspecified soft tissue disorders, not elsewhere classified
|
10.6
|
7.2
|
1.48 (1.08, 2.03) b
|
|
L30
|
Other and unspecified dermatitis
|
10.6
|
7.3
|
1.44 (1.05, 1.98) b
|
|
L30
|
Personal history of medical treatment
|
10.6
|
7.7
|
1.38 (1.01, 1.89) b
|
|
Q66
|
Congenital deformities of feet
|
10.3
|
8.0
|
1.29 (0.94, 1.77)
|
|
I83
|
Varicose veins of lower extremities
|
10.3
|
8.8
|
1.18 (0.86, 1.62)
|
|
E79
|
Disorders of purine and pyrimidine metabolism
|
10.1
|
6.8
|
1.49 (1.08, 2.06) b
|
|
T78
|
Adverse events, not elsewhere classified
|
10.1
|
5.9
|
1.71 (1.23, 2.37) b
|
